Details for Patent: 10,709,671
✉ Email this page to a colleague
Which drugs does patent 10,709,671 protect, and when does it expire?
Patent 10,709,671 protects EPIDIOLEX and is included in one NDA.
This patent has fifteen patent family members in eight countries.
Summary for Patent: 10,709,671
| Title: | Use of cannabinoids in the treatment of epilepsy |
| Abstract: | The present invention relates to the use of cannabidiol (CBD) in the treatment of focal seizures. In one embodiment the patients suffering from focal seizures are children and young adults. CBD appears particularly effective in reducing focal seizures in patients suffering with etiologies that include: Lennox-Gastaut Syndrome; Tuberous Sclerosis Complex; Dravet Syndrome; CDKL5; Neuronal ceroid lipofuscinoses (NCL); febrile infection related epilepsy syndrome (FIRES); Aicardi syndrome and brain abnormalities in comparison to other seizure types. Significantly CBD additionally is very effective in the reduction of a sub-type of focal seizures, focal seizures with impairment. |
| Inventor(s): | Guy; Geoffrey (Cambridge, GB), Wright; Stephen (Cambridge, GB), Devinsky; Orrin (New York, NY) |
| Assignee: | GW Research Limited (Cambridge, GB) |
| Application Number: | 15/183,947 |
|
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 10,709,671
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jazz Pharms Res | EPIDIOLEX | cannabidiol | SOLUTION;ORAL | 210365-001 | Sep 28, 2018 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | USE FOR THE TREATMENT OF FOCAL SEIZURES IN PATIENTS WITH DRAVET SYNDROME | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 10,709,671
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| United Kingdom | 1510664.4 | Jun 17, 2015 |
International Family Members for US Patent 10,709,671
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2016278088 | ⤷ Try a Trial | |||
| Australia | 2021269374 | ⤷ Try a Trial | |||
| Canada | 2989779 | ⤷ Try a Trial | |||
| European Patent Office | 3310390 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
